Total Payments
$3,461
2024 Payments
$191.49
Companies
37
Transactions
231
Medicare Patients
11,091
Medicare Billing
$458,861
Payment Breakdown by Category
Food & Beverage$3,438 (99.3%)
Education$23.80 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,438 | 229 | 99.3% |
| Education | $23.80 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $405.43 | 29 | $0 (2024) |
| Lilly USA, LLC | $290.16 | 15 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $269.85 | 22 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $250.13 | 16 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.38 | 14 | $0 (2019) |
| PFIZER INC. | $226.95 | 22 | $0 (2024) |
| Amgen Inc. | $191.53 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $155.32 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $146.42 | 11 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $143.51 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $191.49 | 11 | Amgen Inc. ($64.29) |
| 2023 | $125.99 | 9 | Novo Nordisk Inc ($68.10) |
| 2022 | $276.95 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($130.77) |
| 2021 | $117.91 | 7 | AbbVie Inc. ($42.30) |
| 2020 | $67.45 | 5 | Arbor Pharmaceuticals, Inc. ($15.32) |
| 2019 | $522.77 | 40 | Novo Nordisk Inc ($113.70) |
| 2018 | $354.63 | 28 | Novo Nordisk Inc ($58.92) |
| 2017 | $1,804 | 120 | Merck Sharp & Dohme Corporation ($230.22) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes Care | ||||||
| 07/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 03/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VACCINES | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 08/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 08/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Obesity | ||||||
| 03/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 02/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Obesity | ||||||
| 01/24/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Obesity | ||||||
| 01/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.65 | General |
| 11/03/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.25 | General |
| 10/12/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, MENVEO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: VACCINES | ||||||
| 09/12/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Obesity | ||||||
| 06/27/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Obesity | ||||||
| 06/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $130.77 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,759 | 3,994 | $334,474 | $115,543 |
| 2022 | 39 | 3,083 | 4,381 | $351,566 | $118,026 |
| 2021 | 38 | 2,853 | 4,004 | $331,528 | $128,745 |
| 2020 | 29 | 2,396 | 3,366 | $268,568 | $96,548 |
Total Patients
11,091
Total Services
15,745
Medicare Billing
$458,861
Procedure Codes
144
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 434 | $91,140 | $32,836 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $60,705 | $26,014 | 42.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $12,896 | $7,341 | 56.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 232 | 366 | $21,960 | $6,024 | 27.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 140 | 182 | $13,650 | $5,280 | 38.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 229 | 348 | $15,660 | $4,566 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 236 | 372 | $22,320 | $3,850 | 17.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 245 | 444 | $11,100 | $3,730 | 33.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $8,816 | $3,270 | 37.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 170 | 250 | $8,750 | $2,380 | 27.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 209 | 307 | $9,210 | $1,946 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 32 | $4,800 | $1,837 | 38.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,300 | $1,802 | 54.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 39 | 44 | $3,080 | $1,780 | 57.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 57 | $3,135 | $1,663 | 53.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 58 | 77 | $4,620 | $1,278 | 27.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,360 | $1,223 | 89.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 37 | 37 | $2,035 | $1,079 | 53.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 52 | 62 | $2,790 | $916.36 | 32.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 39 | 39 | $1,560 | $850.86 | 54.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 93 | $5,208 | $808.38 | 15.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 21 | 21 | $5,859 | $744.66 | 12.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 60 | 80 | $4,000 | $707.20 | 17.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 35 | 35 | $2,800 | $662.20 | 23.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 32 | 44 | $2,068 | $587.84 | 28.4% |
About Dr. Anette Bodoky, M.D
Dr. Anette Bodoky, M.D is a Family Medicine healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1134358682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anette Bodoky, M.D has received a total of $3,461 in payments from pharmaceutical and medical device companies, with $191.49 received in 2024. These payments were reported across 231 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,438).
As a Medicare-enrolled provider, Bodoky has provided services to 11,091 Medicare beneficiaries, totaling 15,745 services with total Medicare billing of $458,861. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Leland, NC
- Active Since 07/06/2009
- Last Updated 04/15/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1134358682
Products in Payments
- JARDIANCE (Drug) $248.63
- FARXIGA (Drug) $213.13
- JANUVIA (Drug) $164.10
- ENTRESTO (Drug) $155.32
- XIFAXAN (Drug) $143.51
- Saxenda (Drug) $140.48
- TRULICITY (Drug) $138.09
- Otezla (Drug) $106.69
- Belviq (Drug) $95.22
- CONTRAVE (Drug) $76.88
- INVOKANA (Drug) $76.36
- Wegovy (Drug) $70.08
- BELSOMRA (Drug) $69.83
- Vascepa (Drug) $68.76
- LINZESS (Drug) $63.59
- ANORO (Drug) $63.32
- Edarbi (Drug) $62.07
- XARELTO (Drug) $59.46
- Tresiba (Drug) $56.21
- SOLIQUA (Drug) $56.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Leland
Kira Alatar, Md, MD
Family Medicine — Payments: $6,634
Family Medicine $6,634
Robert Johnson, Md, MD
Family Medicine — Payments: $5,711
Family Medicine $5,711
Dr. Lekeshia Jarrett, Md, MD
Family Medicine — Payments: $2,607
Family Medicine $2,607
Gloria Vreeland, M.d, M.D
Family Medicine — Payments: $1,629
Family Medicine $1,629
Rajya Atluri, M.d, M.D
Family Medicine — Payments: $1,041
Family Medicine $1,041
Joana Carnahan, D.o, D.O
Family Medicine — Payments: $994.40
Family Medicine $994.40